Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/82294
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): Present and future

AutorPeréz-Pérez, María-Jesús CSIC ORCID ; Priego, Eva María CSIC ORCID; Hernández, Ana-Isabel CSIC; Familiar, Olga CSIC; Camarasa Rius, María José CSIC ORCID; Negri, Ana; Gago, Federico CSIC ORCID; Balzarini, Jan
Fecha de publicación2008
EditorJohn Wiley & Sons
CitaciónMedicinal Research Reviews 28: 797- 820 (2008)
ResumenHuman mitochondrial thymidine kinase (TK2) is a pyrimidine deoxynucleoside kinase (dNK) that catalyzes the phosphorylation of pyrimidine deoxynucleosides to their corresponding deoxynucleoside 5′-monophosphates by γ-phosphoryl transfer from ATP. In resting cells, TK2 is suggested to play a key role in the mitochondrial salvage pathway to provide pyrimidine nucleotides for mitochondrial DNA (mtDNA) synthesis and maintenance. However, recently the physiological role of TK2 turned out to have direct clinical relevance as well. Point mutations in the gene encoding TK2 have been correlated to mtDNA disorders in a heterogeneous group of patients suffering from the so-called mtDNA depletion syndrome (MDS). TK2 activity could also be involved in mitochondrial toxicity associated to prolonged treatment with antiviral nucleoside analogues like AZT and FIAU. Therefore, TK2 inhibitors can be considered as valuable tools to unravel the role of TK2 in the maintenance and homeostasis of mitochondrial nucleotide pools and mtDNA, and to clarify the contribution of TK2 activity to mitochondrial toxicity of certain antivirale. Highly selective TK-2 inhibitors having an acyclic nucleoside structure and efficiently discriminating between TK-2 and the closely related TK-1 have already been reported. It is actually unclear whether these agents efficiently reach the inner mitochondrial compartment. In the present review article, structural features of TK2, MDS-related mutations observed in TK2 and their role in MDS will be discussed. Also, an update on novel and selective TK2 inhibitors will be provided. © 2008 Wiley Periodicals, Inc.
URIhttp://hdl.handle.net/10261/82294
DOI10.1002/med.20124
Identificadoresdoi: 10.1002/med.20124
issn: 0198-6325
e-issn: 1098-1128
Aparece en las colecciones: (IQM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

3
checked on 12-mar-2024

SCOPUSTM   
Citations

21
checked on 27-mar-2024

WEB OF SCIENCETM
Citations

19
checked on 29-feb-2024

Page view(s)

344
checked on 28-mar-2024

Download(s)

111
checked on 28-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.